This technique can detect a population of 5 percent abnormal cells. PCR may be used to detect one abnormal cell in 104 normal cells, when low level residual disease detection is required. The abnormal cells do not have to be the dominant cell population. The unique expression of cellular markers allows for classification of neoplastic cells and identification of multiple subclones or tumor heterogeneity. DNA ploidy analysis identifies aneuploid populations and allows for ascertainment of the proliferative potential of the tumor.
Stat reports are available on request.
A board certified laboratory Director reviews results and signs the final report. This report is telephoned or faxed to the referring physician. Written reports, which include full interpretations, karyotypes, recommendations and references when applicable, are then mailed. Physician consultation is available for all cases. Our research laboratory has already developed high throughput, cost-effective platforms in anticipation of predispositional testing .